Gentium ( GENT) is engaged in the research and development of drugs derived from DNA and DNA molecules. This stock closed up 5.2% to $19.31 in Wednesday's trading session.
Wednesday's Volume: 353,000
Three-Month Average Volume: 79,169
Volume % Change: 265%
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts